Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

893 Paid interests (3) - Net cash (used for) /generated by financing activities 3,022 893 Net increase (decrease) in cash flow and cash equivalents 16,845 (6,522) Cash and cash equivalents at the start of the period 30,356 40,111 Effect of exchange rates modifications (335) 25 Cash and cash equivalents at the end of the period 46,866 33,614 Unaudited consolidated statement of changes in equity In '000 Euro - Share Share Cumulative Other According to capital premium translation reserves IFRS differences Balance sheet at 31 Dec. 2007 110,309 15,647 9 (21,476) Net result 2008 Conversion of 894 warrants by ThromboGenics Ltd Contribution in kind Thrombogenics Ltd shares 777 86 (863) Exchange rate differences as a result of retranslation of foreign subsidiary 4 Share based payments 304 Fair-Value Adjustment Investments (58) Balance sheet at 30 Jun 2008 111,086 15,733 13 (21,199) In '000 Euro - Retained Attributable Minority Total According to IFRS earnings to shareholders interests of the company Balance sheet at 31 Dec. 2007 (56,054) 48,435 - 48,435 Net result 2008 18,028 18,028 1
'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Green & Grow Inc. (GGI) has ... and secured Otter Capital as a significant new partner. ... of GGI’s Agriplier™ technology, building on recent compelling field ... our first meeting, we have been impressed with Otter ... said Alan Sobba, President and CEO of GGI. “We ...
(Date:8/27/2014)... survive impact by the huge amounts of energy ... energy for photosynthesis. The hypothesis is that the ... the energy throughout the entire protein molecule through ... now managed to successfully ,film, this process. , ... which play a role in photosynthesis and thus ...
(Date:8/27/2014)... , Aug. 27, 2014  A novel ... to help physicians better identify early-stage disease, when ... disability, according to a new study in The ... Diagnostics (NYSE: DGX ) and other ... 14-3-3eta protein outperformed conventional antibody-serum testing, including rheumatoid ...
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... the "Global Enzyme for Pulp & Paper Industry ... The Global Enzyme for Pulp & Paper Industry ... the current state of the global enzyme for pulp ... basic overview of the industry including definitions, classifications, applications ...
Breaking Biology Technology:Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3DTU researchers film protein quake for the first time 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Global Enzyme for Pulp & Paper Industry Report 2014 2
... PAREXEL International,Corporation (Nasdaq: PRXL ) will release ... August 6, 2008 after the close of the stock,market. ... http://www.parexel.com and on the PR Newswire website at ... conference call and live webcast at 10:00 a.m. EDT,on ...
... a leading provider of outsourced CFO-level financial and management services for ... as Partner to its Boston office. Strickland is the latest partner ... last year. , ... Cambridge, MA (PRWEB) July 8, ...
... July 7 American Oriental,Bioengineering, Inc. (NYSE: ... to market conditions and other factors, $85 million ... to qualified,institutional buyers in a private placement exempt ... 1933, as amended (the "Securities,Act")., AOB currently ...
Cached Biology Technology:PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call 2TechCFO Adds Gary Strickland as Partner in Boston Office 2American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes 2American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes 3
(Date:8/28/2014)... delivering compounds that could positively impact the ... be possible, thanks to researchers in Penn ... vaginal suppository made from the seaweed-derived food ... drug Tenofovir provides a woman-initiated, drug-delivery vehicle ... sexually transmitted infections during unprotected heterosexual intercourse, ...
(Date:8/28/2014)... kilometres of new roads will be built worldwide by ... last wildernesses, where they bring an influx of destructive ... ambitious study has created a ,global roadmap, for prioritising ... the competing demands of development and environmental protection. , ... estimates that natural importance of ecosystems and a ,road-benefits, ...
(Date:8/28/2014)... Protected areas conserve biodiversity and more action is needed ... areas, researchers say. , Published in PLOS ONE ... University of Exeter, used meta-analysis - combining results from ... years of research into these areas, to determine whether ... School of Biological Sciences, said protecting an area from ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Protected areas proven to protect biodiversity 2
... at the University of Pennsylvania School of Medicine identified ... Epstein-Barr Virus (EBV) protein known to be expressed in ... new mechanism by which EBV can transform human B ... can lead to B-cell lymphomas. Now, they have found ...
... the forthcoming Quarterly Review of Biology, biologists from Binghamton ... laughter ?laughter which is stimulus-driven and laughter which is ... everyday social interaction in response to banal comments and ... and David Sloan Wilson. "The unstated issue is whether ...
... Earth's landscape , The ice ages made massive changes to ... in the oceans? , Research by marine scientists reveals that ... of animals were wiped out by ice sheets scouring the ... that these ecosystems somehow dodged extinction by recolonising from nearby ...
Cached Biology News:Mechanism for Epstein-Barr virus protein's role in blood cancers discovered 2Gene therapy may protect normal tissues during radiation retreatment for lung cancer 2
... Membrane Protein 2, Synaptobrevin 2). ... homology with any other known ... expected that the antibody will ... multata and bovine due to ...
... encodes two unrelated proteins both of which ... cell cycle in a p53-dependent manner. p14^ARF^ ... degradation of mdm2 proteinrequired for mdm2 modification ... This interaction is mediated by the exon ...
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
...
Biology Products: